Drug Database
A04AA01 ondansetron
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Ondansetron 2 mg/ml Solution for Injection
- POM Ondansetron 2 mg/ml Solution for Injection
- POM Ondansetron 2 mg/ml Solution for Injection or Infusion
- POM Ondansetron 2 mg/ml solution for injection/infusion
- POM Ondansetron 2 mg/ml Solution for Injection/Infusion
- POM Ondansetron 2mg/ml Solution for Injection
- POM Ondansetron 2mg/ml Solution for Injection or Infusion
- POM Ondansetron 4 mg film-coated tablets
- POM Ondansetron 4 mg film-coated tablets
- POM Ondansetron 4 mg Film-coated Tablets
- POM Ondansetron 4mg Film-Coated Tablets
- POM Ondansetron 4mg Ordodispersible Tablets
- POM Ondansetron 4mg/5ml Oral Solution
- POM Ondansetron 4mg/5ml Syrup
- POM Ondansetron 4mg/5ml Syrup
- POM Ondansetron 8 mg film-coated tablets
- POM Ondansetron 8 mg film-coated tablets
- POM Ondansetron 8 mg orodispersible tablets
- POM Ondansetron 8mg Film-Coated Tablets
- POM Ondansetron 8mg Orodispersible Tablets
- POM Ondansetron 8mg/5ml oral solution
- POM Setofilm 4mg
- POM Setofilm 8mg
- POM Zofran Injection, Flexi-Amp Injection
- POM Zofran Melt 4mg and 8mg
- POM Zofran Tablets 4mg and 8mg
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).